Drug Shortage Report for APO-TAMSULOSIN CR

Last updated on 2021-02-23 History
Report ID 123581
Drug Identification Number 02362406
Brand name APO-TAMSULOSIN CR
Common or Proper name TAMSULOSIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) TAMSULOSIN HYDROCHLORIDE
Strength(s) 0.4MG
Dosage form(s) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 500 BTL
ATC code G04CA
ATC description DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-31
Estimated end date 2021-02-26
Actual end date 2021-02-19
Shortage status Resolved
Updated date 2021-02-23
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2021-02-23 French Compare
v11 2021-02-23 English Compare
v10 2020-12-28 French Compare
v9 2020-12-28 English Compare
v8 2020-12-11 French Compare
v7 2020-12-11 English Compare
v6 2020-10-23 French Compare
v5 2020-10-23 English Compare
v4 2020-09-11 French Compare
v3 2020-09-11 English Compare
v2 2020-09-02 French Compare
v1 2020-09-02 English Compare

Showing 1 to 12 of 12